Clinical Trials Browser

Colonic Neoplasms × ropidoxuridine × Clear all

NCT02381561 2026-03-18

Ropidoxuridine in Treating Patients With Advanced Gastrointestinal Cancer Undergoing Radiation Therapy

Phase 1 Active not recruiting

Gastrointestinal

Colonic Neoplasms, Esophageal Neoplasms, Liver Neoplasms, Rectal Neoplasms, Stomach Neoplasms